These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36930114)

  • 1. Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population.
    Fang H; Zhang Q; Jin L
    Medicine (Baltimore); 2023 Mar; 102(11):e33202. PubMed ID: 36930114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease.
    Wu HC; Lee LC; Wang WJ
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27645611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower serum beta-2 microglobulin levels are associated with worse survival in incident peritoneal dialysis patients.
    Chang TI; Lim H; Park CH; Park KS; Park JT; Kang EW; Yoo TH; Kang SW; Han SH
    Nephrol Dial Transplant; 2019 Jan; 34(1):138-145. PubMed ID: 29955831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum β-2 microglobulin predicts mortality in people with diabetes.
    Cheung CL; Lam KS; Cheung BM
    Eur J Endocrinol; 2013 Jul; 169(1):1-7. PubMed ID: 23572083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
    Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
    Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis.
    Shi F; Sun L; Kaptoge S
    Atherosclerosis; 2021 Mar; 320():70-78. PubMed ID: 33581388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population.
    Huang Y; Lin Y; Zhai X; Cheng L
    Front Cardiovasc Med; 2022; 9():834150. PubMed ID: 35647083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
    Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
    Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum β2-microglobulin and mortality in Japanese peritoneal dialysis patients: A cohort study.
    Maruyama Y; Nakayama M; Abe M; Yokoo T; Minakuchi J; Nitta K
    PLoS One; 2022; 17(4):e0266882. PubMed ID: 35421178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
    Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.
    Foster MC; Inker LA; Levey AS; Selvin E; Eckfeldt J; Juraschek SP; Coresh J;
    Am J Kidney Dis; 2013 Jul; 62(1):42-51. PubMed ID: 23518194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkaline phosphatase and mortality in patients on peritoneal dialysis.
    Liu X; Guo Q; Feng X; Wang J; Wu J; Mao H; Huang F; Yu X; Yang X
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):771-8. PubMed ID: 24458081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study.
    Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Oh KH; Han SH; Kim SW;
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the serum albumin level with prognosis in chronic kidney disease patients.
    Song H; Wei C; Hu H; Wan Q
    Int Urol Nephrol; 2022 Sep; 54(9):2421-2431. PubMed ID: 35230608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
    Amighi J; Hoke M; Mlekusch W; Schlager O; Exner M; Haumer M; Pernicka E; Koppensteiner R; Minar E; Rumpold H; Schillinger M; Wagner O
    Stroke; 2011 Jul; 42(7):1826-33. PubMed ID: 21546482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC).
    Prizment AE; Linabery AM; Lutsey PL; Selvin E; Nelson HH; Folsom AR; Church TR; Drake CG; Platz EA; Joshu C
    Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):657-64. PubMed ID: 26908438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of anemia and chronic kidney disease on the risk of cardiovascular disease and all-cause mortality among diabetic patients].
    Yang C; Wang JW; Yang YZ; Bai KH; Gao BX; Zhao MH; Zhang LX; Wu SL; Wang F
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):495-500. PubMed ID: 29930419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy-Adjusted Dietary Inflammatory Index Is Associated With 5-Year All Cause and Cardiovascular Mortality Among Chronic Kidney Disease Patients.
    Huang Y; Zhang L; Zeng M; Liu F; Sun L; Liu Y; Xiao L
    Front Nutr; 2022; 9():899004. PubMed ID: 35774544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.